NEWS HIGHLIGHTS
Published Studies Related to Adenoscan (Adenosine)
The effect of PDRN, an adenosine receptor A2A agonist, on the healing of chronic
diabetic foot ulcers: results of a clinical trial. [2014] ulcer healing in patients with diabetes... CONCLUSIONS: PDRN facilitates the healing of Wagner 1 or 2 diabetic foot ulcers.
Efficacy and safety of a novel dual modulator of adenosine triphosphate-citrate
lyase and adenosine monophosphate-activated protein kinase in patients with
hypercholesterolemia: results of a multicenter, randomized, double-blind,
placebo-controlled, parallel-group trial. [2013] treating hypercholesterolemia and other cardiometabolic risk factors... CONCLUSIONS: ETC-1002 significantly lowered LDL-C levels up to 27% across a broad
The new oral adenosine A1 receptor agonist capadenoson in male patients with
stable angina. [2012] capadenoson in patients with stable angina... CONCLUSIONS: In patients with stable angina capadenoson lowers exercise HR at
Treatment of Unexplained Syncope: A Multicenter, Randomized Trial of Cardiac Pacing Guided by Adenosine 5'-triphosphate Testing. [2011.11.15] CONCLUSIONS: This study suggests that, in elderly patients with SUO and positive ATP tests, active dual-chamber pacing reduces syncope recurrence risk by 75% (95% CI 44% to 88%). CLINICAL TRIAL REGISTRATION INFORMATION: http://www.controlled-trials.com/ISRCTN00029383; Unique Identifier: ISRCTN00029383.
Adenosine A2(A) receptor gene polymorphism (1976C>T) affects coronary flow reserve response during vasodilator stress testing in patients with non ischemic-dilated cardiomyopathy. [2011.08] OBJECTIVES: Patients with non ischemic-dilated cardiomyopathy (DCM) are characterized by an activation of the adenosinergic system and reduced coronary flow reserve (CFR) evaluated by transthoracic Doppler echocardiography during vasodilator adenosinergic stress (dipyridamole administration). The aim of this study was to assess whether genetic polymorphisms (263C>T and 1976C>T) of the A2(A) receptor gene affect CFR response in patients with DCM... CONCLUSION: These data demonstrate that A2(A) 1976C>T polymorphism is associated with a blunted coronary vasodilatory response in patients with DCM, and support a direct consequences of this single nucleotide polymorphism for protein expression. Additional studies are needed to better define the functional role of this genetic variant as well as to clarify the potential clinical impact of genetics during pharmacological stress cardiac imaging.
Clinical Trials Related to Adenoscan (Adenosine)
ADVANCE MPI 2: Study of Regadenoson Versus Adenoscan® in Patients Undergoing Myocardial Perfusion Imaging (MPI) [Completed]
Adenoscan® (adenosine) is an approved pharmacological stress agent indicated as an adjunct
to thallium-201 myocardial perfusion scintigraphy in patients unable to exercise adequately.
The investigational drug, regadenoson (CVT-3146) is a selective A2A adenosine receptor
agonist, the receptor responsible for coronary vasodilation, and is being studied for
potential use as a pharmacologic stress agent in myocardial perfusion imaging (MPI) studies.
This study will compare the safety and efficacy of regadenoson to that of Adenoscan in
detecting reversible myocardial perfusion defects.
ADVANCE MPI 1: Study of Regadenoson Versus Adenoscan® in Patients Undergoing Myocardial Perfusion Imaging (MPI) [Completed]
Adenoscan® (adenosine) is an approved pharmacological stress agent indicated as an adjunct
to thallium-201 myocardial perfusion scintigraphy in patients unable to exercise adequately.
The investigational drug, regadenoson (CVT-3146) is a selective A2A adenosine receptor
agonist, the receptor responsible for coronary vasodilation, and is being studied for
potential use as a pharmacologic stress agent in myocardial perfusion imaging (MPI) studies.
This study will compare the safety and efficacy of regadenoson to that of Adenoscan in
detecting reversible myocardial perfusion defects.
Intravenous Regadenoson Versus Intravenous Adenoscan® for Fractional Flow Reserve (FFR) [Recruiting]
Myocardial Protection With Adenosine Preconditioning [Completed]
Adenosine has been proved to be an important mediator of myocardial protection induced by
ischemic preconditioning. The hypothesis of this study is that adenosine preconditioning can
provide additional myocardial protection in the setting of pediatric open heart surgery with
cardioplegia and cardiopulmonary bypass.
Effect of Ticagrelor vs. Dipyridamole on Adenosine Uptake [Active, not recruiting]
The investigators are trying to determine if a single dose of Ticagrelor will increase
delivery of intraarterially-infused adenosine into the forearm interstitium, consistent with
adenosine reuptake blockade.
Reports of Suspected Adenoscan (Adenosine) Side Effects
Coronary Artery Disease (8),
Hypertension (3),
Anaemia Postoperative (2),
Diabetes Mellitus Inadequate Control (2),
Supraventricular Tachycardia (2),
Hyperlipidaemia (2),
Ventricular Tachycardia (2),
Ischaemic Cardiomyopathy (1),
Angina Unstable (1),
Haemodynamic Instability (1), more >>
|